XILIARX 50 mg TABLETS
How to use XILIARX 50 mg TABLETS
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet: Information for the User
Xiliarx 50mg tablets
vildagliptina
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your doctor, pharmacist, or nurse.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the pack:
- What is Xiliarx and what is it used for
- What you need to know before you take Xiliarx
- How to take Xiliarx
- Possible side effects
- Storage of Xiliarx
- Contents of the pack and other information
1. What is Xiliarx and what is it used for
The active substance of Xiliarx, vildagliptina, belongs to a group of medicines called «oral antidiabetics».
Xiliarx is used to treat adult patients with type 2 diabetes when diabetes cannot be controlled by diet and exercise alone. It helps to control blood sugar levels. Your doctor will prescribe Xiliarx alone or in combination with other antidiabetic medicines that you are already taking if they are not effective enough to control your diabetes.
Type 2 diabetes appears when the body does not produce enough insulin or when the insulin produced does not work properly. It can also appear when the body produces too much glucagon.
Insulin is a substance that helps to reduce blood sugar levels, especially after meals. Glucagon is a substance that promotes the production of sugar by the liver and increases blood sugar levels. Both substances are produced in the pancreas.
How Xiliarx works
Xiliarx stimulates the pancreas to produce more insulin and less glucagon. This helps to control blood sugar levels. This medicine has been shown to reduce blood sugar, which will help to prevent complications of your diabetes.
Although you start taking this medicine for your diabetes, it is important that you continue with the diet and/or exercise that your doctor has recommended.
2. What you need to know before you take Xiliarx
Do not take Xiliarx
- if you are allergic to vildagliptina or any of the other ingredients of this medicine (listed in section 6). If you think you may be allergic to vildagliptina or any other ingredient of Xiliarx, do not take this medicine and consult your doctor.
Warnings and precautions
Consult your doctor, pharmacist, or nursebefore you start taking Xiliarx
- if you have type 1 diabetes (i.e., your body does not produce insulin) or if you have a condition called diabetic ketoacidosis.
- if you are taking an antidiabetic medicine known as a sulfonylurea (your doctor may want to reduce your dose of sulfonylurea when taken in combination with Xiliarx to avoid low blood sugar levels [hypoglycemia]).
- if you have moderate or severe kidney disease (you will need to take a lower dose of Xiliarx).
- if you are undergoing dialysis.
- if you have liver disease.
- if you have heart failure.
- if you have or have had pancreatitis.
If you have previously taken vildagliptina but had to stop taking it due to liver disease, you should not take this medicine.
Skin lesions are common complications of diabetes. Follow your doctor's or nurse's recommendations for skin and foot care, paying special attention to the appearance of blisters or ulcers while taking Xiliarx. If this occurs, you should consult your doctor as soon as possible.
Liver function tests should be performed before starting treatment with Xiliarx, at intervals of three months during the first year, and periodically thereafter. This is done to detect any signs of increased liver enzymes (transaminases) as soon as possible.
Children and adolescents
The administration of Xiliarx is not recommended in children and adolescents under 18 years of age.
Use of Xiliarx with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Your doctor may change your dose of Xiliarx if you are taking other medicines such as:
- thiazides or other diuretics (also called water pills)
- corticosteroids (generally used to treat inflammation)
- thyroid medicines
- certain medicines that affect the nervous system.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
You should not use Xiliarx during pregnancy. It is not known if Xiliarx passes into breast milk. You should not take Xiliarx if you are breastfeeding or plan to breastfeed.
Driving and using machines
If you feel dizzy while taking Xiliarx, do not drive or operate tools or machines.
Xiliarx contains lactose
Xiliarx contains lactose (milk sugar). If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Xiliarx contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially “sodium-free”.
3. How to take Xiliarx
Follow exactly the instructions of administration of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
How much to take and when
The dose of Xiliarx that you should take varies depending on your condition. Your doctor will tell you exactly how many Xiliarx tablets to take.
The maximum daily dose is 100 mg.
The recommended dose of Xiliarx is:
- 50 mg once daily in the morning if you are taking Xiliarx with another medicine known as a sulfonylurea.
- 100 mg daily in two doses of 50 mg in the morning and evening if you are taking Xiliarx alone, with another medicine known as metformin, or with a glitazone, with a combination of metformin and a sulfonylurea, or with insulin.
- 50 mg daily in the morning if you have moderate or severe kidney disease or if you are undergoing dialysis.
How to take Xiliarx
- Swallow the tablet whole with a little water.
Duration of treatment with Xiliarx
- Take Xiliarx every day as long as your doctor indicates. You may need to continue this treatment for a long time.
- Your doctor will perform periodic checks to ensure that the treatment has the desired effect.
If you take more Xiliarx than you should
If you have taken too many Xiliarx tablets or if someone else has taken your medicine, consult your doctor immediately.You may need medical attention. If you have to visit a doctor or go to the nearest hospital, take the package with you.
If you forget to take Xiliarx
If you forget to take a dose of this medicine, take it as soon as you remember. Then take the next dose at the usual time. If it is almost time for the next dose, skip the missed dose. Do not take a double dose to make up for forgotten doses.
If you stop taking Xiliarx
Do not stop taking Xiliarx unless your doctor tells you to. If you have doubts about the duration of treatment with Xiliarx, consult your doctor.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some symptoms require immediate medical attention
You should stop taking Xiliarx and consult your doctor immediately if you experience any of the following side effects:
- Angioedema (rare: may affect up to 1 in 1,000 people): symptoms including swollen face, tongue, or throat, difficulty swallowing, difficulty breathing, sudden appearance of rash or hives, which may be indicative of a reaction called “angioedema”.
- Liver disease (hepatitis) (frequency not known): symptoms including yellowing of the skin and eyes, nausea, loss of appetite, or dark urine, which may be indicative of liver disease (hepatitis).
- Pancreatitis (rare: may affect up to 1 in 1,000 people): symptoms including severe and persistent abdominal pain (stomach area), which may radiate to the back, as well as nausea and vomiting.
Other side effects
Some patients experienced the following side effects while taking Xiliarx:
- Very common (may affect more than 1 in 10 people): sore throat, nasal congestion, fever.
- Common (may affect up to 1 in 10 people): itchy rash, tremor, headache, dizziness, muscle pain, joint pain, swollen hands, ankles, or feet (edema), excessive sweating, vomiting, stomach pain, and abdominal pain (abdominal discomfort), diarrhea, heartburn, nausea (discomfort), blurred vision.
- Uncommon (may affect up to 1 in 100 people): weight gain, chills, weakness, sexual dysfunction, low blood sugar levels, flatulence.
- Rare (may affect up to 1 in 1,000 people): pancreatitis.
Since the marketing of this product, the following side effects have also been reported:
- Frequency not known (cannot be estimated from the available data): localized skin peeling or blisters, inflammation of blood vessels (vasculitis) that can cause skin rashes or red, flat, round spots under the skin surface or bruising.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Xiliarx
- Keep this medicine out of the sight and reach of children.
- Do not use this medicine after the expiry date which is stated on the blister and on the carton after “EXP”/”CAD”. The expiry date is the last day of the month shown.
- Store in the original package to protect from moisture.
- Do not use Xiliarx if you notice that the package is damaged or shows signs of deterioration.
- Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
6. Contents of the pack and other information
Composition of Xiliarx
- The active substance is vildagliptina.
Each tablet contains 50 mg of vildagliptina.
- The other ingredients are anhydrous lactose, microcrystalline cellulose, sodium starch glycolate (type A), and magnesium stearate.
Appearance of the product and pack contents
Xiliarx 50 mg tablets are white to slightly yellowish, flat, round tablets with «NVR» on one side and «FB» on the other.
Xiliarx 50 mg tablets are available in packs containing 7, 14, 28, 30, 56, 60, 90, 112, 180, or 336 tablets, and in multipacks consisting of 3 packs, each containing 112 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Ireland
Manufacturer
Lek d.d.
Verovskova ulica 57
Ljubljana 1526
Slovenia
Novartis Farmacéutica S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain
Novartis Pharma GmbH
Roonstrasse 25
D-90429 Nuremberg
Germany
Novartis Pharmaceutical Manufacturing LLC
Verovskova ulica 57
Ljubljana 1000
Slovenia
Novartis Pharma GmbH
Sophie-Germain-Strasse 10
90443 Nürnberg
Germany
You can obtain further information on this medicine from the local representative of the marketing authorisation holder:
BelgiumNovartis Pharma N.V. Tel: +32 2 246 16 11 | Lithuania UAB Novartis Baltics Lietuvos filialas Tel: +370 5 269 16 50 |
Bulgaria Novartis Bulgaria EOOD Phone: +359 2 489 98 28 | LuxembourgNovartis Pharma N.V. Tel: +32 2 246 16 11 |
Czech Republic Novartis s.r.o. Phone: +420 225 775 111 | HungaryNovartis Hungária Kft. Phone: +36 1 457 65 00 |
Denmark Novartis Healthcare A/S Phone: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Phone: +356 2122 2872 |
Germany Novartis Pharma GmbH Phone: +49 911 273 0 | Netherlands Novartis Pharma B.V. Phone: +31 88 04 52 111 |
Estonia Novartis Baltics Eesti filiaal Phone: +372 66 30 810 | Norway Novartis Norge AS Phone: +47 23 05 20 00 |
Greece Novartis (Hellas) A.E.B.E. Phone: +30 210 281 17 12 | Austria Novartis Pharma GmbH Phone: +43 1 86 6570 |
Spain Laboratorios Gebro Pharma, S.A. Phone: +34 93 205 86 86 | Poland Novartis Poland Sp. z o.o. Phone: +48 22 375 4888 |
France Novartis Pharma S.A.S. Phone: +33 1 55 47 66 00 | Portugal Laboratório Normal – Produtos Farmacêuticos Lda. Phone: +351 21 000 8600 |
Croatia Novartis Hrvatska d.o.o. Phone: +385 1 6274 220 | Romania Novartis Pharma Services Romania SRL Phone: +40 21 31299 01 |
Ireland Novartis Ireland Limited Phone: +353 1 260 12 55 | Slovenia Novartis Pharma Services Inc. Phone: +386 1 300 75 50 |
Iceland Vistor hf. Phone: +354 535 7000 | Slovakia Novartis Slovakia s.r.o. Phone: +421 2 5542 5439 |
Italy Novartis Farma S.p.A. Phone: +39 02 96 54 1 | Finland Novartis Finland Oy Phone: +358 (0)10 6133 200 |
Cyprus Novartis Pharma Services Inc. Phone: +357 22 690 690 | Sweden Novartis Sverige AB Phone: +46 8 732 32 00 |
Latvia SIA Novartis Baltics Phone: +371 67 887 070 |
Date of last revision of this leaflet:
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu
- Country of registration
- Average pharmacy price15.61 EUR
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to XILIARX 50 mg TABLETSDosage form: TABLET, 50 mgActive substance: vildagliptinManufacturer: Novartis Europharm LimitedPrescription requiredDosage form: TABLET, 50 mgActive substance: vildagliptinManufacturer: Novartis Europharm LimitedPrescription requiredDosage form: TABLET, 50 mgActive substance: vildagliptinManufacturer: Novartis Europharm LimitedPrescription required
Online doctors for XILIARX 50 mg TABLETS
Discuss questions about XILIARX 50 mg TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions
